Comprehensive Analysis of the Therapeutic IgG4 Antibody Pembrolizumab: Hinge Modification Blocks Half Molecule Exchange In Vitro and In Vivo-Reference-Cited by-同舟云学术

Comprehensive Analysis of the Therapeutic IgG4 Antibody Pembrolizumab: Hinge Modification Blocks Half Molecule Exchange In Vitro and In Vivo

Published:2015-12 Issue:12 Volume:104 Page:4002-4014
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Yang Xiaoyu,Wang Fengqiang,Zhang Ying,Wang Larry,Antonenko Svetlana,Zhang Shuli,Zhang Yi Wei,Tabrizifard Mohammad,Ermakov Grigori,Wiswell Derek,Beaumont Maribel,Liu Liming,Richardson Daisy,Shameem Mohammed,Ambrogelly Alexandre

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference37 articles.

1. Antibodies to watch in 2014;Reichert;mAbs,2014

2. Which are the antibodies to watch in 2012?;Reichert;mAbs,2012

3. Which are the antibodies to watch in 2013?;Reichert;mAbs,2013

4. Therapeutic antibodies for human diseases at the dawn of the twenty-first century;Brekke;Nat Rev Drug Discov,2003

5. Improving the efficacy of antibody-based cancer therapies;Carter;Nat Rev Cancer,2001

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small-Angle X-ray Scattering as a Powerful Tool for Phase and Crystallinity Assessment of Monoclonal Antibody Crystallites in Support of Batch Crystallization;Molecular Pharmaceutics;2024-07-03

2. Fc–Fc interactions and immune inhibitory effects of IgG4: implications for anti-PD-1 immunotherapies;Journal for ImmunoTherapy of Cancer;2024-06

3. Structure and function of therapeutic antibodies approved by the US FDA in 2023;Antibody Therapeutics;2024-03-19

4. Immune-oncological drug pembrolizumab;Quantum Chemistry Methods for Oncological Drugs;2024

5. A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants;Frontiers in Immunology;2023-09-26